New Study Says Two Million Americans Harbor Drug-Resistant SuperbugDecember 22, 2005New research estimates that about 2 million people carry a strain of drug-resistant bacteria in their noses. The research, conducted by the Centers for Disease Control and Prevention (CDC), is the first reliable nationwide estimate of colonization with Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). It is published in the Jan. 15 issue of The Journal of Infectious Diseases, now available online. Those colonized with normal strains of staph are at higher risk of infection with the bacterium, which can lead to conditions ranging from mild skin infections to fatal toxic shock syndrome. MRSA causes more difficult-to-treat and, sometimes, more virulent illnesses. MRSA was once primarily a problem in hospitals, but is now a growing problem in communities around the country. Matthew J. Kuehnert, MD, and colleagues collected samples from nearly 10,000 participants in the 2001-2002 National Health and Nutritional Examination Survey, a representative sample of the U.S. population.
Nearly one-third were found to be colonized with staph. Prevalence was highest among males and children between 6 and 11 years old. MRSA prevalence was 0.8 percent. MRSA was highest among women and those older than 60, but those colonized with strains commonly associated with community-associated MRSA were more likely to be younger and black. Overall, strains and toxins previously found to be associated with community-associated MRSA were unusual. The genetic diversity of strains was remarkable-about half of isolates, including MRSA strains, had unique molecular fingerprinting patterns, and some fell outside recognized groups. "There is a lot about staph colonization we don't know," Dr. Kuehnert said. "Interestingly, carriage of certain strains do seem to vary by sociodemographics, especially age and race. We need to learn more in order to allow design of new, more effective interventions," he added, including vaccines or antimicrobial treatment. "Data from subsequent survey years may determine whether there are ongoing trends in colonization." In an accompanying editorial, Clarence Buddy Creech II, MD, of Vanderbilt University and colleagues observe that, "In light of the increasing frequency of community-associated MRSA infection, new antimicrobials are needed," although an effective vaccine against staph would provide a more permanent solution. The Journal of Infectious Diseases | |||||||||||||||||||||
|
Related Drug-resistant Bacteria News Articles Green tea helps beat superbugs Green tea can help beat superbugs according to Egyptian scientists speaking today (Monday 31 March 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre. New chemical can kill latent tuberculosis bacteria Success in the laboratory suggests that a new compound can point the way to preventing active tuberculosis in people infected with the latent form of the bacterium, says a team led by researchers at Weill Cornell Medical College in New York City. Silica smart bombs deliver knock-out to bacteria Bacteria mutate for a living, evading antibiotic drugs while killing tens of thousands of people in the United States each year. Poultry workers at increased risk of carrying antibiotic-resistant E. coli Poultry workers in the United States are 32 times more likely to carry E. coli bacteria resistant to the commonly used antibiotic, gentamicin, than others outside the poultry industry, according to a recent study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health. Scripps/UC San Diego Scientists Solve Genome of Marine Organism Producing Promising Disease-Fighting Agents Scientists at UC San Diego's Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences have solved the genomic puzzle of an organism discovered in the oceans with potential for producing compounds showing promise in treating diseases such as cancer. Researchers discover how antibiotic inhibits bacterial growth Researchers at the University of Illinois at Chicago, in collaboration with research teams from Pharmacia & Upjohn and Pfizer, have discovered precisely how the antibiotic linezolid inhibits bacterial growth. Fewer heart patients need antibiotics before dental procedures Based on a review of new and existing scientific evidence, most dental patients with heart disease do not need antibiotics before dental procedures to prevent infective endocarditis (IE), a rare, but life-threatening heart infection. Does evolution select for faster evolvers? It's a mystery why the speed and complexity of evolution appear to increase with time. For example, the fossil record indicates that single-celled life first appeared about 3.5 billion years ago, and it then took about 2.5 billion more years for multi-cellular life to evolve. Genetically altered cells may help artificial skin fight infection Cincinnati burn researchers have created genetically modified skin cells that, when added to cultured skin substitutes, may help fight off potentially lethal infections in patients with severe burns. New study reveals structure of E. coli multidrug transporter protein This new study could potentially help researchers find new ways to avoid the problem of multidrug resistance and enhance the potency of existing drug compounds. More Drug-resistant Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||